MALAGUTTI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 1.096
EU - Europa 225
AS - Asia 184
AF - Africa 1
SA - Sud America 1
Totale 1.507
Nazione #
US - Stati Uniti d'America 1.096
CN - Cina 119
UA - Ucraina 76
TR - Turchia 41
DE - Germania 40
GB - Regno Unito 39
SE - Svezia 20
SG - Singapore 19
FI - Finlandia 16
IT - Italia 15
BE - Belgio 7
FR - Francia 6
IN - India 2
RU - Federazione Russa 2
AL - Albania 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
ID - Indonesia 1
IE - Irlanda 1
IQ - Iraq 1
PH - Filippine 1
Totale 1.507
Città #
Woodbridge 177
Fairfield 136
Ann Arbor 101
Chandler 93
Jacksonville 77
Houston 74
Ashburn 60
Wilmington 48
Seattle 44
Beijing 37
Cambridge 36
New York 32
Izmir 22
Princeton 21
Nanjing 18
Shanghai 13
Boardman 12
Singapore 12
Bremen 10
Dearborn 10
San Diego 10
Milan 8
Shenyang 8
Brussels 7
Nanchang 7
Auburn Hills 6
Jiaxing 6
Los Angeles 6
Changsha 5
Jinan 5
Leawood 5
San Mateo 5
Ferrara 4
Philadelphia 4
Tappahannock 3
Tianjin 3
Addison 2
Falls Church 2
Hebei 2
Hefei 2
Indiana 2
Mountain View 2
Norwalk 2
Tucson 2
Verona 2
Washington 2
Zhengzhou 2
Augusta 1
Baghdad 1
Bogotá 1
Changchun 1
Copenhagen 1
Dublin 1
Guangzhou 1
Hangzhou 1
Hounslow 1
Hyderabad 1
Jakarta 1
Kunming 1
Lanzhou 1
Manila 1
Monmouth Junction 1
Nanning 1
Ningbo 1
Olomouc 1
Redwood City 1
Taizhou 1
Tirana 1
Totale 1.168
Nome #
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 143
Reversibility of Left Ventricle Longitudinal Strain Alterations Induced by Adjuvant Therapy in Early Breast Cancer Patients 139
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. 134
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 119
Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress 110
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 108
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction 106
Different clinical models of CD34 plus cells mobilization in patients with cardiovascular disease 101
Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. 80
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 78
Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial 69
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study 69
Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study. 64
Persistent Coronary No Flow After Wire Insertion Is an Early and Readily Available Mortality Risk Factor Despite Successful Mechanical Intervention in Acute Myocardial Infarction A Pooled Analysis From the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) Trials 63
null 61
CD34+ cells mobilization in myocardial infarction: a link with heart failure? 59
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. 24
Totale 1.527
Categoria #
all - tutte 6.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.296


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020347 56 13 12 41 21 39 30 37 21 40 31 6
2020/2021185 18 19 7 21 8 13 7 24 2 25 29 12
2021/2022206 5 21 23 8 9 4 13 10 2 19 24 68
2022/2023193 23 4 8 30 37 28 5 23 22 1 8 4
2023/2024116 12 12 3 2 8 41 6 2 3 3 2 22
Totale 1.527